*Result*: Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab
*Author/editor-in-chief*:
*Publication*:
Freiburg : Universität, 2025
*Physical description scale*:
1 Online-Ressource
*Format*:
*Language*:
*eng*
*Notes*:
JHEP reports. - 7, 3 (2025) , 101295, ISSN: 2589-5559
*DOI*:
10.1016/j.jhepr.2024.101295